244 related articles for article (PubMed ID: 2110500)
1. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment.
Werner-Felmayer G; Werner ER; Fuchs D; Hausen A; Reibnegger G; Wachter H
Cancer Res; 1990 May; 50(10):2863-7. PubMed ID: 2110500
[TBL] [Abstract][Full Text] [Related]
2. Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide.
Meyer KC; Cornwell R; Carlin JM; Powers C; Irizarry A; Byrne GI; Borden EC
Am J Respir Cell Mol Biol; 1992 Jun; 6(6):639-46. PubMed ID: 1591013
[TBL] [Abstract][Full Text] [Related]
3. LPS-induced NF-kappaB expression in THP-1Blue cells correlates with neopterin production and activity of indoleamine 2,3-dioxygenase.
Schroecksnadel S; Jenny M; Kurz K; Klein A; Ledochowski M; Uberall F; Fuchs D
Biochem Biophys Res Commun; 2010 Sep; 399(4):642-6. PubMed ID: 20691158
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-derived dendritic cells release neopterin.
Wirleitner B; Reider D; Ebner S; Böck G; Widner B; Jaeger M; Schennach H; Romani N; Fuchs D
J Leukoc Biol; 2002 Dec; 72(6):1148-53. PubMed ID: 12488496
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrosis factor-alpha and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells.
Werner-Felmayer G; Werner ER; Fuchs D; Hausen A; Reibnegger G; Wachter H
Biol Chem Hoppe Seyler; 1989 Sep; 370(9):1063-9. PubMed ID: 2482041
[TBL] [Abstract][Full Text] [Related]
6. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1.
Weiss G; Fuchs D; Hausen A; Reibnegger G; Werner ER; Werner-Felmayer G; Wachter H
Exp Hematol; 1992 Jun; 20(5):605-10. PubMed ID: 1587306
[TBL] [Abstract][Full Text] [Related]
7. In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS).
Troppmair J; Nachbaur K; Herold M; Aulitzky W; Tilg H; Gastl G; Bieling P; Kotlan B; Flener R; Mull B
Clin Exp Immunol; 1988 Dec; 74(3):392-7. PubMed ID: 3148378
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells.
Kurz K; Gluhcheva Y; Zvetkova E; Konwalinka G; Fuchs D
Immunobiology; 2010 Jun; 215(6):452-7. PubMed ID: 19765856
[TBL] [Abstract][Full Text] [Related]
9. Selective induction of mononuclear phagocytes to produce neopterin by interferons.
Bitterlich G; Szabó G; Werner ER; Larcher C; Fuchs D; Hausen A; Reibnegger G; Schulz TF; Troppmair J; Wachter H
Immunobiology; 1988 Feb; 176(3):228-35. PubMed ID: 2452128
[TBL] [Abstract][Full Text] [Related]
10. Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.
Hahn G; Stuhlmüller B; Hain N; Kalden JR; Pfizenmaier K; Burmester GR
J Clin Invest; 1993 Mar; 91(3):862-70. PubMed ID: 8450066
[TBL] [Abstract][Full Text] [Related]
11. Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.
Carlin JM; Borden EC; Sondel PM; Byrne GI
J Immunol; 1987 Oct; 139(7):2414-8. PubMed ID: 2443564
[TBL] [Abstract][Full Text] [Related]
12. Evidence for increased de novo synthesis of NAD in immune-activated RAW264.7 macrophages: a self-protective mechanism?
Grant RS; Passey R; Matanovic G; Smythe G; Kapoor V
Arch Biochem Biophys; 1999 Dec; 372(1):1-7. PubMed ID: 10562410
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan degradation in patients with gynecological cancer correlates with immune activation.
Schroecksnadel K; Winkler C; Fuith LC; Fuchs D
Cancer Lett; 2005 Jun; 223(2):323-9. PubMed ID: 15896467
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of immune activation using biochemical changes in a porcine model of cardiac arrest.
Amann A; Widner B; Rieder J; Antretter H; Hoffmann G; Mayr V; Strohmenger HU; Fuchs D
Mediators Inflamm; 2001 Dec; 10(6):343-6. PubMed ID: 11817676
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune activation, neopterin production, tryptophan degradation and the development of immunodeficiency.
Widner B; Wirleitner B; Baier-Bitterlich G; Weiss G; Fuchs D
Arch Immunol Ther Exp (Warsz); 2000; 48(4):251-8. PubMed ID: 11059641
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated antigen 90K activates myelomonocytic cell line THP-1.
Altindag ZZ; Marth C; Werner-Felmayer G; Natoli C; Zeimet AG; Wachter H; Iacobelli S; Fuchs D
Cancer Lett; 1996 Oct; 107(1):143-8. PubMed ID: 8913279
[TBL] [Abstract][Full Text] [Related]
17. Increasing production of homocysteine and neopterin and degradation of tryptophan with older age.
Frick B; Schroecksnadel K; Neurauter G; Leblhuber F; Fuchs D
Clin Biochem; 2004 Aug; 37(8):684-7. PubMed ID: 15302611
[TBL] [Abstract][Full Text] [Related]
18. Neopterin, a prognostic marker in human malignancies.
Sucher R; Schroecksnadel K; Weiss G; Margreiter R; Fuchs D; Brandacher G
Cancer Lett; 2010 Jan; 287(1):13-22. PubMed ID: 19500901
[TBL] [Abstract][Full Text] [Related]
19. Induction of indoleamine 2,3-dioxygenase in human cells in vitro.
Werner-Felmayer G; Werner ER; Fuchs D; Hausen A; Reibnegger G; Wachter H
Adv Exp Med Biol; 1991; 294():505-9. PubMed ID: 1722950
[TBL] [Abstract][Full Text] [Related]
20. PADMA 28 modulates interferon-gamma-induced tryptophan degradation and neopterin production in human PBMC in vitro.
Neurauter G; Wirleitner B; Schroecksnadel K; Schennach H; Ueberall F; Fuchs D
Int Immunopharmacol; 2004 Jun; 4(6):833-9. PubMed ID: 15135323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
